Skip to main content
S

Shanghai INT Medical Instruments Co., Ltd. — Investor Relations & Filings

Ticker · 1501 HKEX Manufacturing
Filings indexed 290 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1501

About Shanghai INT Medical Instruments Co., Ltd.

http://www.int-medical.com

Shanghai INT Medical Instruments Co., Ltd. is a leading developer and manufacturer of interventional medical devices, primarily focusing on cardiovascular, peripheral vascular, neurovascular, cardiac electrophysiology, and structural heart disease segments. The company maintains a strong market position due to its complete industrial chain, encompassing independent mold development, equipment manufacturing, and sterilization capabilities. This vertical integration is a key differentiator. INT Medical emphasizes technological innovation, holding extensive intellectual property, including hundreds of authorized patents and numerous product registrations (CE and FDA). Its products are exported globally to over 90 countries and regions.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2026
Regulatory Filings
2026-05-06 English
DISCLOSEABLE TRANSACTION AND CONNECTED TRANSACTION AT THE SUBSIDIARY LEVEL IN RELATION TO THE ACQUISITION OF EQUITY INTERESTS IN A NON-WHOLLY-OWNED SUBSIDIARY
M&A Activity Classification · 1% confidence The document is a formal stock exchange announcement under the Hong Kong Listing Rules describing the acquisition of 35% equity interests in a non-wholly-owned subsidiary and its reclassification as a connected and discloseable transaction under Chapters 14 and 14A. This constitutes an M&A activity (an acquisition of a subsidiary’s equity interests). It is not a fundraising or financing notice, nor a report publication announcement. The appropriate classification is M&A Activity (Code: TAR).
2026-04-29 English
ANNOUNCEMENT OF BOARD RESOLUTION
M&A Activity Classification · 1% confidence The document is an announcement of a board resolution approving the proposed acquisition of equity interest in another company. It details a corporate acquisition transaction rather than a financing, management change, or regular report. This aligns with an M&A Activity announcement (code TAR).
2026-04-28 English
Annual Report 2025
Regulatory Filings
2026-04-22 English
Circular of Annual General Meeting
Proxy Solicitation & Information Statement Classification · 1% confidence The provided document is a comprehensive circular sent to shareholders of Shanghai INT Medical Instruments Co., Ltd. in advance of the Annual General Meeting (AGM). It includes the notice of the AGM, proxy form instructions, explanatory statements (e.g., profit distribution plan, amendments to articles), and attaches key documents such as the directors’ report, supervisory committee report, annual report, audited financial statements, remuneration proposals, auditor re-appointment proposals, and share repurchase mandate. It is clearly a solicitation of shareholder votes and an information statement rather than the standalone annual report itself or a simple publication announcement. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-22 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 28 MAY 2026 AND ANY ADJOURNMENT THEREOF
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Form of Proxy for the company’s Annual General Meeting, sent to shareholders to appoint proxies and vote on resolutions. This is not the meeting materials themselves (AGM-R) nor the results (DVA), but rather a solicitation of proxies and voting instruction, which falls under Proxy Solicitation & Information Statement (PSI).
2026-04-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.